Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OncoGambit was a private digital health and oncology decision-support company that provided personalized cancer treatment recommendations based on published guidelines and expert consensus. The platform was designed to help patients compare or confirm treatment plans using tumor biology, cancer stage, and recommendations aligned with major oncology societies such as NCCN, ASCO, ASTRO, and ESMO. The company also developed survivorship-oriented tools, including hereditary cancer risk assessment and mobile coaching support for breast cancer survivors. Founded in 2015 in Southern California, OncoGambit appears to have operated as a for-profit healthcare technology company and is now listed as permanently closed.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OncoGambit.